UCLA Investing in Analytics for Brain Injury Treatment | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

UCLA Investing in Analytics for Brain Injury Treatment

March 13, 2013
by Gabriel Perna
| Reprints

The University of California at Los Angeles (UCLA) has announced its investing in analytics software from the Armonk, N.Y.-based tech giant IBM, which will test the effectiveness of a real-time alarm that tries and predicts rising brain pressure in patients with traumatic brain injuries. Also joining this collaboration is and Excel Medical Electronics (EME), a Jupiter, Fla.-based data acquisition platform provider.

The system analyzes streams of vital signs collected in real-time from the bedside monitor to spot subtle changes in the patient's pulse, blood and intracranial pressure, heart activity, and respiration. This would signal that dangerous high-risk increases in brain pressure are on the way. The system could allow the nurse or physician to determine if the alarm is false, if the condition is life-threatening, or if immediate action is needed to prevent brain damage or death.

UCLA will be conducting a study on this technology and its effectiveness. Researchers are looking to provide advance warning to physicians and nurses of pending changes in the patient's condition, which would allow for preventive actions from practitioners. UCLA's Department of Neurosurgery was awarded a $1.2 million grant from the National Institute of Neurological Disorders and Stroke to study intracranial pressure and develop a predictive alarm system.

"We believe that UCLA's promising research may one day transform the way that doctors and nurses interact with patients inside the neuro-intensive care unit,” Martin Kohn, MD, chief medical scientist, IBM Research, said in a statement.

In a similar vein, the University of Pittsburgh Medical Center (UPMC) health system recently announced a five-year, $100 million enterprise healthcare analytics initiative to foster personalized medicine and other core strategic healthcare IT goals for the organization, partnering with several prominent vendors—Oracle, IBM, Informatica, and dbMotion.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).